Verrica Pharmaceuticals makes fourth attempt at FDA approval for its lead new drug candidate


Three previous attempts to get the skin disorder treatment approved were not successful.

Previous Tampa's multibillion-dollar water distributor has a new CFO
Next Health tech startup JupiterDX to launch platform for long Covid care